Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism

Kidney International

Volumn 67, Issue 2, 2005, Pages 467-476

  Colloton, Matthew ^b   Shatzen, Edward ^b   Miller, Gerald ^b   Stehman Breen, Catherine ^b   Wada, Michihito ^b   Lacey, David ^b   Martin, David ^a  

^a AMGEN INC   (United States)

^b NONE

Author keywords

Calcium sensing receptor; Cinacalcet HCl; Hyperplasia; PTH; Rodent; Secondary hyperparathyroidism; Uremia

Indexed keywords

BETA CYCLODEXTRIN SULFOBUTYL ETHER; CALCIUM ION; CINACALCET; CYCLINE; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD CHEMISTRY; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DOSE RESPONSE; FEEDING; IMMUNOCHEMISTRY; MALE; NEPHRECTOMY; NONHUMAN; ORGAN WEIGHT; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL; RAT; RAT STRAIN; SECONDARY HYPERPARATHYROIDISM;

EID: 12344277590     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.67103.x     Document Type: Article

References (43)

1. DRUEKE TB: The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 48:259-272, 1995
2. 3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 35:1049-1056, 1989
3. NAVEH-MANY T, RAHAMIMOV R, LIVNI N, et al: Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96:1786-1793, 1995
4. SLATOPOLSKY E, FINCH J, DENDRA M, et al. Phosphorus restriction prevents parathyroid gland growth: High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534-2540, 1996
5. Dusso AS, THADHANI R, SLATOPOLSKY E: Vitamin D receptor and analogs. Semin Nephrol 24:10-16, 2004
6. SLATOPOLSKY E, RUTHERFORD WE, HOFFSTEN PE, et al: Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease. Kidney Int 1:43-51, 1972
7. POTALE AA, BOOTH BE, HALLORAN BP, et al: Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxy-vitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73:1580-1589, 1984
8. NEMETH EF, Fox J: Calcimimetic compounds: A direct approach to controlling plasma levels of parathyroid hormone in hyperparathyroidism. Trends Endocrinol Metab 10:66-71, 1999
9. 2+-sensing receptor from bovine parathyroid. Nature 366:575-580, 1993
10. 2+ receptor. PNAS USA 95:4040-4045, 1998
11. WADA M, FURUYA Y, SAKIYAMA J, et al: The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency: Control of parathyroid cell growth via a calcium receptor. J Clin Invest 100:2977-2983, 1997
12. NEMETH EF, HEATON WH, MILLER M, et al: Pharmacodynamics of the type II calcimimetic compound, cinacalcet HCl. J Pharmacol Exp 308:627-635, 2004
13. LINDBERG JS, SHARON MM, GOODMAN WG, et al: The calcimimetic cinacalcet HCl reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism. Kidney Int 63:248-254, 2003
14. QUARLES LD, SHERRARD DJ, ADLER S, et al: The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease. J Am Soc Nephrol 14:575-583, 2003
15. BLOCK GA, MARTIN KJ, DE FRANCISCO ALM, et al: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516-1525, 2004
16. MARTIN D, DAVIS J, MILLER G, et al: Regression of parathyroid hyperplasia by cinacalcet HCl in a rodent model of chronic kidney disease (CKD). ETDA 2004 (in press)
17. WADA M, NAGANO N, FURUYA Y, et al: Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism. Kidney Int 57:50-58, 2000
18. CHIN J, MILLER SC, WADA M, et al: Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats. J Am Soc Nephol 11:903-911, 2000
19. Fox J, LOWE SH, CONKLIN RL, et al: The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism. Endocrine 10:97-103, 1999
20. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 316:1573-1577, 1987
21. KOIKE T, FUKUDA N, FUKAGAWA M, et al: Correlation of enhanced cell proliferation with decreased density of vitamin D receptor in parathyroid hyperplasia in chronic dialysis patients. Nephrology 3:279-284, 1997
22. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598-1606, 1996
23. BROWN AJ, RITTER CS, FINCH JL, et al: Decreased calcium-sensing receptor expression in hyperplasic parathyroid glands of uremic rats: Role of dietary phosphate. Kidney Int 55:1284-1292, 1999
24. CHATTOPADHYAY N, MITHAL A, BROWN EM: The calcium-sensing receptor: A window into the physiology and pathophysiology of mineral ion metabolism. Endocr Rev 17:289-307, 1996
25. HO C, CONNER DA, POLLAK MR, et al: A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11:389-394, 1995
26. RITTER CS, FINCH JL, SLATOPOLSKY EA, et al: Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney Int 60:1737-1744, 2001
27. VALIMAKI S, FARNEBO F, FORSBERG L, et al: Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism. Kidney Int 60:1666-1675, 2001
28. FARNEBO F, HOOG A, SANDELIN K, et al: Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas. Surgery 124:1094-1099, 1998
29. Li YC, AMLING M, PIRRO AE-M, et al: Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391-4396, 1998
30. SLATOPOLSKY E, WEERTS C, THIELAN J, et al: Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 74:2136-2143, 1984
31. FUKAGAWA M, OKAZAKI R, TAKANO K, et al: Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis. N Engl J Med 323:421-422, 1990
32. DENDA M, FINCH J, SLATOPOLSKY E: Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 28:596-602, 1996
33. 2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. J Bone Miner Res 12:715-725, 1997
34. KIFOR O, MACLEOD RJ, DIAZ R, et al: Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 280:F291-F302, 2001
35. 2+-sensing receptor: A versatile regulator of diverse cellular functions. Vit Horm 55:1-71, 1999
36. WERNERSON A, SYENSSON O, REINHOLT FP: Quantitative and three-dimensional aspects of the rat parathyroid gland in normo-, hypo, and hypercalcemia. Microsc Res Tech 32:129-147, 1995
37. WERNERSON A, SYENSSON O, REINHOLT FP: Parathyroid cell number and size in hypercalcemic rats: A stereologic study using modern unbiased estimators. J Bone Miner Res 4:705-713, 1989
38. LEBOFF MS, RENNKE HG, BROWN EM: Abnormal regulation of parathyroid cell secretion and proliferation in primary cultures of bovine parathyroid cells. Endocrinology 113:277-284, 1983
39. KREMER R, BOLIVAR I, GOLTZMAN D, et al: Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125:935-941, 1989
40. 3 of cell proliferation and function of bovine parathyroid cells in culture. J Bone Min Res 5:755-760, 1990
41. ROUSSANNE M-C, LIEBERHERR M, SOUBERBIELLE JC, et al: Human parathyroid cell proliferation in response to calcium, NPS R-457, calcitriol and phosphate. Eur J Clin Invest 31:610-616, 2001
42. MARTIN D, COLLOTON M, SHATZEN E, et al: Cinacalcet HCl decreases PTH and blood ionized calcium in rodent models of chronic renal insufficiency (CRI) accompanied by secondary hyperparathyroidism (HPT). J Am Soc Nephrol 14:462A, 2003
43. 2+ receptor in rats. J Pharmacol Exper Ther 290:480-486, 1999